Taryn Rogalski-Salter joined Gates Medical Research Institute in 2018 to build the global regulatory affairs organization and is responsible developing and implementing regulatory strategy across the portfolio of candidates.  Prior to this, Taryn led global regulatory affairs organizations at Novartis, Novartis Vaccines, Takeda Vaccines and established the Global Regulatory Policy Network at Merck.  Throughout her career, she was directly involved with the global licensure of over a dozen vaccines and participated in the response to declared pandemics and multiple disease outbreaks.  Her expertise includes Process Development, Manufacturing Technical Services, Bioanalytical Development, Global Regulatory Policy and Regulatory Affairs.  Taryn received her PhD from Dartmouth College and conducted her thesis research on applied genetic and metabolic engineering at Dartmouth's Thayer School of Engineering.